Development and validation of an immunoluminometric assay (ILMA) for fetuin-A-glycoprotein

J Immunoassay Immunochem. 2010;31(1):10-23. doi: 10.1080/15321810903404830.

Abstract

Background: To identify dialysis patients with low fetuin-A levels, a sensitive immunoluminometric assay (ILMA) was developed.

Methods: For the two-site ILMA, one monoclonal antibody was coated to polystyrene beads and one polyclonal antibody was labelled with acridinium ester.

Results: The lower detection threshold was 0.013 g/L, with the normal range 0.20-0.87 g/L (arithmetic mean 0.437 +/- 0.118 g/L). Serum fetuin-A levels in the dialysis patients were significantly lower (arithmetic mean: 0.352 +/- 0.099 g/L, p < 0.0001).

Conclusion: This ILMA has been proved to be a reliable method for the determination of serum fetuin-A concentrations in dialysis patients.

Publication types

  • Validation Study

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Blood Proteins / analysis*
  • Blood Proteins / immunology
  • Case-Control Studies
  • Female
  • Humans
  • Immunoassay / methods*
  • Kidney Diseases / blood
  • Kidney Diseases / therapy
  • Limit of Detection
  • Male
  • Reference Standards
  • Renal Dialysis
  • alpha-2-HS-Glycoprotein

Substances

  • AHSG protein, human
  • Antibodies, Monoclonal
  • Blood Proteins
  • alpha-2-HS-Glycoprotein